Symbolbild · KI-generiert
Eastwood Bio-Medical Canada Inc.
Stock factsheet
Company data from public sources (TMX Money, Canadian Securities Exchange, Nasdaq screener, Wikidata); every ISIN is verified against its check digit. Where „—“ appears, no verified value exists — we do not publish unverified identifiers. Market capitalisation is an order of magnitude as of the date shown, not a real-time figure. The size class follows the thresholds in common use (micro < $300m, small < $2bn, mid < $10bn) and is meant as an indication, not a definition.
Company profile
Eastwood Bio-Medical Canada Inc is engaged in the development and commercialization of safe and effective treatment for non-insulin-dependent diabetes mellitus (NIDDM-Type II diabetes). The company's Eleotin brand of products provides naturally sourced solutions for metabolic syndromes such as blood glucose control, obesity, and hypertension. Eleotin was initially developed by the scientists at the Julia McFarlane Diabetes Research Center (JMDRC) at the University of Calgary in Alberta, Canada. After the initial development by the JMDRC, research and development were continued by Eastwood Bio-Medical Research Inc., the company, and other institutions around the world, including Tsinghua University of the People's Republic of China.
Company description as published by the issuer via TMX Money.
Comparable companies
Companies in the Biotech & Pharma sector of a similar size.
| Company | Ticker | Exchange | Market cap |
|---|---|---|---|
| Eastwood Bio-Medical Canada Inc. | EBM | TSXV | 48 Mio. USD |
| Realbotix Corp. | XBOT | TSXV | 46 Mio. USD |
| Covalon Technologies Ltd. | COV | TSXV | 44 Mio. USD |
| TelyRx Holdings Inc. Subordinate Voting Shares | TELY | TSX | 52 Mio. USD |
| Ocumetics Technology Corp. | OTC | TSXV | 43 Mio. USD |
| Theralase Technologies Inc. | TLT | TSXV | 52 Mio. USD |
| ME Therapeutics Holdings Inc. | METX | CSE | 53 Mio. USD |
Investor Relations
We link only to primary sources from the company itself and from the regulators. Fields we have not recorded stay empty until a reliable source is available.
Information and education only — not investment advice, not a recommendation and not a financial analysis within the meaning of §85 WpHG or Art. 20 MAR. Investments in small and micro caps are highly speculative; total loss is possible. All information without warranty.